ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000266289.1	Avagacestat	Bladder urothelial carcinoma	0.021434027	Resistant
ENSG00000266289.1	Avagacestat	Colon adenocarcinoma	0.011473849	Sensitive